Lucid Diligence Brief: Novo Nordisk to acquire Akero Therapeutics for up to $5.2 billion
Lucid Diligence Brief: Novo Nordisk to acquire Akero Therapeutics for up to…
Latest Vaccine Research News - Sept 19th - Oct 2nd 2025
Watch Our Video Summary Capturing Top Vaccine News from the Last Two Weeks…
Rare Diseases Weekly News - August 7th 2025
🧬 This Week in Rare Diseases: Europe’s R&D at Risk, AI Drug Discovery, New…
Rare Diseases Weekly News - June 26th 2025
🧬 This Week in Rare Diseases: Genome Testing, First Approvals, Global…
Navigating the Biosimilar Landscape: What to watch out in 2024 and Beyond
The anticipated expiration of exclusivity rights for major biologics in 2022…
How Gene Therapy sponsors can overcome regulatory approval bottlenecks.
In a previous article, we discussed the findings of a Linkedin poll regarding…
